J. Bjelke

发表

Tyrosine 547 Constitutes an Essential Part of the Catalytic Mechanism of Dipeptidyl Peptidase IV*

Sven Branner, S. Branner, Nicolai Wagtmann, 2004, Journal of Biological Chemistry.

Mechanism of the Ca2+-induced Enhancement of the Intrinsic Factor VIIa Activity*

O. Olsen, B. Kragelund, E. Persson, 2008, Journal of Biological Chemistry.

Prolonging coagulant activity of factor Xa under hemophilic conditions by site-specific N-glycosylation of the surface-exposed autolysis loop

O. Olsen, J. Winther, Peter Tiainen, 2021, bioRxiv.

The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice

S. Paludan, L. Reinert, S. Vang, 2021, eLife.

Engineering of Substrate Selectivity for Tissue Factor·Factor VIIa Complex Signaling through Protease-activated Receptor 2*

O. Olsen, W. Ruf, Henrik Østergaard, 2010, The Journal of Biological Chemistry.

A factor VIIIa–mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice

K. Lamberth, G. Røder, Per Greisen, 2021, Blood.

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

T. Nichols, Henrik Østergaard, T. N. Krogh, 2011, Blood.

A loop of coagulation factor VIIa influencing macromolecular substrate specificity

O. Olsen, B. Kragelund, E. Persson, 2007, FEBS letters.

SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.

J. Jardine, K. Iversen, M. Loftager, 2020, Journal of immunology.

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individuals

J. Jardine, K. Iversen, M. Loftager, 2020, medRxiv.

In vitro and in silico assessment of the developability of a designed monoclonal antibody library

M. Vendruscolo, D. Otzen, L. De Maria, 2019, mAbs.

SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain

J. Jardine, S. Paludan, F. Öberg, 2021, The Journal of Immunology.

Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.

P. F. Nielsen, S. Branner, J. Bjelke, 2006, The Biochemical journal.

Design of Biopharmaceutical Formulations Accelerated by Machine Learning.

A. Butté, P. Arosio, Nikolai Lorenzen, 2021, Molecular pharmaceutics.

Hyperglycosylation prolongs the circulation of coagulation factor IX

J. Bjelke, G. Bolt, D. Karpf, 2012, Journal of thrombosis and haemostasis : JTH.

Engineering the substrate and inhibitor specificities of human coagulation Factor VIIa.

O. Olsen, B. Kragelund, Henrik Østergaard, 2007, The Biochemical journal.

Non-specificity fingerprints for clinical stage antibodies in solution

T. Knowles, Nikolai Lorenzen, T. Herling, 2023, bioRxiv.

Modulating the Antithrombin-Mediated in Vivo Clearance of Coagulation Factor VIIa

O. Olsen, Henrik Østergaard, H. Stennicke, 2014 .

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide.

T. Nichols, Henrik Østergaard, F. Møller, 2011, Blood.

A factor VIIIa – mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice

K. Lamberth, Per Greisen, B. G. Hansen, 2021 .

Predicting G Using Hypers rain Protein Content in Wheat pectral Sensing of In-season Crop Partial Least Squares Regression

J. Bjelke, 2006 .

Purification de polypeptides

J. Bjelke, 2009 .

Selectivity among dipeptidyl peptidases of the S9b family.

J. Bjelke, A. Kanstrup, H. Rasmussen, 2006, Cellular and molecular biology.